GeneFirst dispose d’un riche portefeuille de technologies brevetées, à savoir: MPA (multiplex Probe Amplification) TBD-Seq (Tagged BiDirectional Sequencing) MMD-PCR (Multiplex Mutation Detection PCR) PCDR (Polymerase Chain Displacement Reaction) Human papillomavirus (HPV) and Cervical cancer → Read more Cell-free DNA in plasma and Cancer → Read […]
